Literature DB >> 22553500

Disruption of protein quality control in Parkinson's disease.

Casey Cook1, Caroline Stetler, Leonard Petrucelli.   

Abstract

Parkinson's disease (PD), like a number of neurodegenerative diseases associated with aging, is characterized by the abnormal accumulation of protein in a specific subset of neurons. Although researchers have recently elucidated the genetic causes of PD, much remains unknown about what causes increased protein deposition in the disease. Given that increased protein aggregation may result not only from an increase in production, but also from decreased protein clearance, it is imperative to investigate both possibilities as potential PD culprits. This article provides a review of the systems that regulate protein clearance, including the ubiquitin proteasome system (UPS) and the autophagy-lysosomal pathway. Literature implicating failure of these mechanisms-such as UPS dysfunction resulting from environmental toxins and mutations in α-synuclein and parkin, as well as macroautophagic pathway failure because of oxidative stress and aging-in the pathogenesis of PD is also discussed.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22553500      PMCID: PMC3331692          DOI: 10.1101/cshperspect.a009423

Source DB:  PubMed          Journal:  Cold Spring Harb Perspect Med        ISSN: 2157-1422            Impact factor:   6.915


  136 in total

1.  Proteins are unfolded on the surface of the ATPase ring before transport into the proteasome.

Authors:  A Navon; A L Goldberg
Journal:  Mol Cell       Date:  2001-12       Impact factor: 17.970

2.  Proteasomal inhibition leads to formation of ubiquitin/alpha-synuclein-immunoreactive inclusions in PC12 cells.

Authors:  H J Rideout; K E Larsen; D Sulzer; L Stefanis
Journal:  J Neurochem       Date:  2001-08       Impact factor: 5.372

3.  Expression of A53T mutant but not wild-type alpha-synuclein in PC12 cells induces alterations of the ubiquitin-dependent degradation system, loss of dopamine release, and autophagic cell death.

Authors:  L Stefanis; K E Larsen; H J Rideout; D Sulzer; L A Greene
Journal:  J Neurosci       Date:  2001-12-15       Impact factor: 6.167

Review 4.  Mechanisms underlying ubiquitination.

Authors:  C M Pickart
Journal:  Annu Rev Biochem       Date:  2001       Impact factor: 23.643

5.  Residual structure and dynamics in Parkinson's disease-associated mutants of alpha-synuclein.

Authors:  R Bussell; D Eliezer
Journal:  J Biol Chem       Date:  2001-10-04       Impact factor: 5.157

6.  alpha-synuclein metabolism and aggregation is linked to ubiquitin-independent degradation by the proteasome.

Authors:  G K Tofaris; R Layfield; M G Spillantini
Journal:  FEBS Lett       Date:  2001-11-30       Impact factor: 4.124

7.  Gaucher disease and parkinsonism: a phenotypic and genotypic characterization.

Authors:  N Tayebi; M Callahan; V Madike; B K Stubblefield; E Orvisky; D Krasnewich; J J Fillano; E Sidransky
Journal:  Mol Genet Metab       Date:  2001-08       Impact factor: 4.797

8.  Phosphorylated alpha-synuclein at Ser-129 is targeted to the proteasome pathway in a ubiquitin-independent manner.

Authors:  Youhei Machiya; Susumu Hara; Shigeki Arawaka; Shingo Fukushima; Hiroyasu Sato; Masahiro Sakamoto; Shingo Koyama; Takeo Kato
Journal:  J Biol Chem       Date:  2010-10-19       Impact factor: 5.157

9.  The herbicide paraquat causes up-regulation and aggregation of alpha-synuclein in mice: paraquat and alpha-synuclein.

Authors:  Amy B Manning-Bog; Alison L McCormack; Jie Li; Vladimir N Uversky; Anthony L Fink; Donato A Di Monte
Journal:  J Biol Chem       Date:  2001-11-13       Impact factor: 5.157

10.  Chaperone-mediated autophagy markers in Parkinson disease brains.

Authors:  Lydia Alvarez-Erviti; Maria C Rodriguez-Oroz; J Mark Cooper; Cristina Caballero; Isidro Ferrer; Jose A Obeso; Anthony H V Schapira
Journal:  Arch Neurol       Date:  2010-08-09
View more
  60 in total

1.  HMGB1 is involved in autophagy inhibition caused by SNCA/α-synuclein overexpression: a process modulated by the natural autophagy inducer corynoxine B.

Authors:  Ju-Xian Song; Jia-Hong Lu; Liang-Feng Liu; Lei-Lei Chen; Siva Sundara Kumar Durairajan; Zhenyu Yue; Hong-Qi Zhang; Min Li
Journal:  Autophagy       Date:  2013-01-01       Impact factor: 16.016

Review 2.  Proteostasis in endoplasmic reticulum--new mechanisms in kidney disease.

Authors:  Reiko Inagi; Yu Ishimoto; Masaomi Nangaku
Journal:  Nat Rev Nephrol       Date:  2014-04-22       Impact factor: 28.314

3.  Decreased proteasomal activity causes photoreceptor degeneration in mice.

Authors:  Ryo Ando; Kousuke Noda; Utano Tomaru; Mamoru Kamoshita; Yoko Ozawa; Shoji Notomi; Toshio Hisatomi; Mika Noda; Atsuhiro Kanda; Tatsuro Ishibashi; Masanori Kasahara; Susumu Ishida
Journal:  Invest Ophthalmol Vis Sci       Date:  2014-07-03       Impact factor: 4.799

Review 4.  Exosomes in Toxicology: Relevance to Chemical Exposure and Pathogenesis of Environmentally Linked Diseases.

Authors:  Dilshan S Harischandra; Shivani Ghaisas; Dharmin Rokad; Anumantha G Kanthasamy
Journal:  Toxicol Sci       Date:  2017-07-01       Impact factor: 4.849

5.  Proteasomal inhibition as a treatment strategy for Parkinson's disease: the impact of α-synuclein on Nurr1.

Authors:  Michael J Devine
Journal:  J Neurosci       Date:  2012-11-14       Impact factor: 6.167

Review 6.  Metabolic Dysfunction in Parkinson's Disease: Bioenergetics, Redox Homeostasis and Central Carbon Metabolism.

Authors:  Annadurai Anandhan; Maria S Jacome; Shulei Lei; Pablo Hernandez-Franco; Aglaia Pappa; Mihalis I Panayiotidis; Robert Powers; Rodrigo Franco
Journal:  Brain Res Bull       Date:  2017-03-21       Impact factor: 4.077

Review 7.  The implication of neuronimmunoendocrine (NIE) modulatory network in the pathophysiologic process of Parkinson's disease.

Authors:  Yan Shen; Xingfang Guo; Chao Han; Fang Wan; Kai Ma; Shiyi Guo; Luxi Wang; Yun Xia; Ling Liu; Zhicheng Lin; Jinsha Huang; Nian Xiong; Tao Wang
Journal:  Cell Mol Life Sci       Date:  2017-06-16       Impact factor: 9.261

8.  Overexpression of alpha-synuclein at non-toxic levels increases dopaminergic cell death induced by copper exposure via modulation of protein degradation pathways.

Authors:  Annadurai Anandhan; Humberto Rodriguez-Rocha; Iryna Bohovych; Amy M Griggs; Laura Zavala-Flores; Elsa M Reyes-Reyes; Javier Seravalli; Lia A Stanciu; Jaekwon Lee; Jean-Christophe Rochet; Oleh Khalimonchuk; Rodrigo Franco
Journal:  Neurobiol Dis       Date:  2014-12-08       Impact factor: 5.996

Review 9.  Mitochondrial Quality Control Proteases in Neuronal Welfare.

Authors:  Roman M Levytskyy; Edward M Germany; Oleh Khalimonchuk
Journal:  J Neuroimmune Pharmacol       Date:  2016-05-02       Impact factor: 4.147

Review 10.  Neural and immune mechanisms in the pathogenesis of Parkinson's disease.

Authors:  Fabio Blandini
Journal:  J Neuroimmune Pharmacol       Date:  2013-02-03       Impact factor: 4.147

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.